Top Story

Generic latanoprost may yield improved adherence for open-angle glaucoma treatment

February 25, 2015

Patients with open-angle glaucoma who switch from a brand-name prostaglandin analogue to generic latanoprost may adhere better to medical treatment, according to a study.

The longitudinal cohort analysis compared adherence rates by 8,427 patients during the 18 months before the availability of generic latanoprost and the 18 months after the generic treatment became available. The adherence of patients who continued use of brand-name prostaglandins was compared with those who switched to generic latanoprost after it became available.

Perspectives on Glaucoma

Tests vary in identifying glaucoma progression

February 23, 2015
Three tests used in glaucoma diagnosis and management demonstrated varied results in a study recently published in Investigational Ophthalmology and Visual
Perspectives on Glaucoma

Patient compliance improves with use of generic glaucoma drugs

February 20, 2015
Patients who switched to generic latanoprost were more likely to adhere to their drug regimens, according to a study recently published in Ophthalmology.Stein and…
Perspectives on Glaucoma

Glaucoma surgery associated with IOP rise in fellow eye

February 19, 2015
Following glaucoma surgery in one eye, researchers found that intraocular pressure rose in the fellow eye, according to a study recently published in the Journal of
CME
Postoperative Inflammation and Pain

Postoperative Inflammation and Pain: Elimination of the Dynamic Duo to Improve Patient Outcomes

This activity is supported by an educational grant from Bausch + Lomb.

Cataract surgery has improved in both safety and outcomes in recent years. With advances in surgical techniques…
More »
Meeting News Coverage Video
thumbnail for video 4043173891001

VIDEO: Innovative imaging may change glaucoma research, diagnosis

February 11, 2015
SAN FRANCISCO – At Glaucoma 360, Richard L. Lindstrom, MD, discusses a new consortium funded by the Glaucoma…
More »
In the Journals

Generic latanoprost may yield improved adherence for open-angle glaucoma treatment

February 25, 2015
Patients with open-angle glaucoma who switch from a brand-name prostaglandin analogue to generic latanoprost may adhere better to medical treatment…
Perspectives on Glaucoma

Tests vary in identifying glaucoma progression

February 23, 2015
Three tests used in glaucoma diagnosis and management demonstrated varied results in a study recently published in Investigational Ophthalmology and
Perspectives on Glaucoma

Patient compliance improves with use of generic glaucoma drugs

February 20, 2015
Patients who switched to generic latanoprost were more likely to adhere to their drug regimens, according to a study recently published in…
Perspectives on Glaucoma

Glaucoma surgery associated with IOP rise in fellow eye

February 19, 2015
Following glaucoma surgery in one eye, researchers found that intraocular pressure rose in the fellow eye, according to a study recently published in…
Perspectives on Glaucoma

Presence of coronary artery calcification associated with higher IOP

February 13, 2015
Intraocular pressure is significantly associated with subclinical atherosclerosis, according to a study recently published in the British Journal of
thumbnail for video 4043133720001 Meeting News CoverageVideo

VIDEO: Panelist discusses challenges, best practices for bringing products to market

February 12, 2015
SAN FRANCISCO – At Glaucoma 360, Richard L. Lindstrom, MD, gives highlights from a panel discussion focused on teaching the best methods as…
thumbnail for video 4043173891001 Meeting News CoverageVideo

VIDEO: Innovative imaging may change glaucoma research, diagnosis

February 11, 2015
SAN FRANCISCO – At Glaucoma 360, Richard L. Lindstrom, MD, discusses a new consortium funded by the Glaucoma Research foundation, which should…
Samuelson th Meeting News CoverageVideo

VIDEO: Range of MIGS devices in development continues to expand

February 10, 2015
SAN FRANCISCO – Thomas W. Samuelson, MD, highlights upcoming discussions at Glaucoma 360.

Envisia initiates phase 2a clinical trial for glaucoma treatment

February 9, 2015
Envisia Therapeutics has initiated a phase 2a clinical trial of ENV515, a possible treatment for patients with glaucoma, the company announced in a…
Meeting News Coverage

Glaucoma innovation needs to move to earlier treatment

February 9, 2015
SAN FRANCISCO — Moving glaucoma innovation to focus on early treatment will save money and improve patient quality of life, according to the…
More Headlines »
morganatic-roan